56
Views
1
CrossRef citations to date
0
Altmetric
Theme: Vascular Disease - Review

Selection and timing for invasive therapy in non-ST-segment-elevation acute coronary syndrome

, , , &
Pages 437-445 | Published online: 10 Jan 2014

References

  • Bassand JP. Impact of anaemia, bleeding, and transfusions in acute coronary syndromes: a shift in the paradigm. Eur. Heart J. 28(11), 1273–1274 (2007).
  • Meier P, Seiler C. The coronary collateral circulation – clinical relevances and therapeutic options. Heart doi:10.1136/heartjnl-2012-303426 (2012) (Epub ahead of print).
  • Terkelsen CJ, Lassen JF, Nørgaard BL et al. Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort. Eur. Heart J. 26(1), 18–26 (2005).
  • Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N. Engl. J. Med. 362(23), 2155–2165 (2010).
  • Hamm CW, Bassand JP, Agewall S et al.; ESC Committee for Practice Guidelines; Document Reviewers. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 32(23), 2999–3054 (2011).
  • de Winter RJ, Windhausen F, Cornel JH et al.; Invasive versus Conservative Treatment in Unstable Coronary Syndromes (ICTUS) Investigators. Early invasive versus selectively invasive management for acute coronary syndromes. N. Engl. J. Med. 353(11), 1095–1104 (2005).
  • Wallentin L, Lagerqvist B, Husted S, Kontny F, Ståhle E, Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease. Lancet 356(9223), 9–16 (2000).
  • Lagerqvist B, Husted S, Kontny F, Ståhle E, Swahn E, Wallentin L; Fast Revascularisation during InStability in Coronary artery disease (FRISC-II) Investigators. 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study. Lancet 368(9540), 998–1004 (2006).
  • Fox KA, Poole-Wilson PA, Henderson RA et al.; Randomized Intervention Trial of unstable Angina Investigators. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet 360(9335), 743–751 (2002).
  • Alfredsson J, Lindbäck J, Wallentin L, Swahn E. Similar outcome with an invasive strategy in men and women with non-ST-elevation acute coronary syndromes: from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). Eur. Heart J. 32(24), 3128–3136 (2011).
  • Cannon CP, Weintraub WS, Demopoulos LA et al.; TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)–Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N. Engl. J. Med. 344(25), 1879–1887 (2001).
  • Boden WE, O’Rourke RA, Crawford MH et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. N. Engl. J. Med. 338(25), 1785–1792 (1998).
  • Damman P, Hirsch A, Windhausen F, Tijssen JG, de Winter RJ; ICTUS Investigators. 5-year clinical outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) trial a randomized comparison of an early invasive versus selective invasive management in patients with non-ST-segment elevation acute coronary syndrome. J. Am. Coll. Cardiol. 55(9), 858–864 (2010).
  • Fox KA, Clayton TC, Damman P et al.; FIR Collaboration. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. J. Am. Coll. Cardiol. 55(22), 2435–2445 (2010).
  • Bhatt DL, Roe MT, Peterson ED et al.; CRUSADE Investigators. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA 292(17), 2096–2104 (2004).
  • Simms AD, Reynolds S, Pieper K et al. Evaluation of the NICE mini-GRACE risk scores for acute myocardial infarction using the Myocardial Ischaemia National Audit Project (MINAP) 2003–2009: National Institute for Cardiovascular Outcomes Research (NICOR). Heart 99(1), 35–40(2012).
  • Antman EM, Cohen M, Bernink PJ et al. The TIMI risk score for unstable angina/non-ST-segment-elevation MI: a method for prognostication and therapeutic decision making. JAMA 284(7), 835–842 (2000).
  • Aragam KG, Tamhane UU, Kline-Rogers E et al. Does simplicity compromise accuracy in ACS risk prediction? A retrospective analysis of the TIMI and GRACE risk scores. PLoS ONE 4(11), e7947 (2009).
  • D’Ascenzo F, Biondi-Zoccai G, Moretti C et al. TIMI, GRACE and alternative risk scores in acute coronary syndromes: a meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients. Contemp. Clin. Trials 33(3), 507–514 (2012).
  • Morrow DA, Sabatine MS, Brennan ML et al. Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: mmyeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18. Eur. Heart J. 29(9), 1096–1102 (2008).
  • Stone GW, Maehara A, Lansky AJ et al.; PROSPECT Investigators. A prospective natural-history study of coronary atherosclerosis. N. Engl. J. Med. 364(3), 226–235 (2011).
  • Lindsay AC, Viceconte N, Di Mario C. Optical coherence tomography: has its time come? Heart 97(17), 1361–1362 (2011).
  • Kern MJ, Samady H. Current concepts of integrated coronary physiology in the catheterization laboratory. J. Am. Coll. Cardiol. 55(3), 173–185 (2010).
  • Tonino PA, De Bruyne B, Pijls NH et al.; FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N. Engl. J. Med. 360(3), 213–224 (2009).
  • Sels JW, Tonino PA, Siebert U et al. Fractional flow reserve in unstable angina and non-ST-segment elevation myocardial infarction experience from the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) study. JACC Cardiovasc. Interv. 4(11), 1183–1189 (2011).
  • O’Donoghue M, Boden WE, Braunwald E et al. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. JAMA 300(1), 71–80 (2008).
  • Lagerqvist B, Säfström K, Ståhle E, Wallentin L, Swahn E; FRISC II Study Group Investigators. Is early invasive treatment of unstable coronary artery disease equally effective for both women and men? FRISC II Study Group Investigators. J. Am. Coll. Cardiol. 38(1), 41–48 (2001).
  • Elkoustaf RA, Mamkin I, Mather JF et al. Comparison of results of percutaneous coronary intervention for non-ST-elevation acute myocardial infarction or unstable angina pectoris in men versus women. Am. J. Cardiol. 98(2), 182–186 (2006).
  • Kumbhani DJ, Shishehbor MH, Willis JM et al. Influence of gender on long-term mortality in patients presenting with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention. Am. J. Cardiol. 109(8), 1087–1091 (2012).
  • Liistro F, Ducci K, Falsini G, Bolognese L. Early invasive strategy in elderly patients with non-ST-elevation acute coronary syndromes. Eur. Heart J. Suppl. 7, K23–K25 (2005).
  • Leoncini M, Maioli M, Bellandi F et al. Therapeutic strategies, immediate and mid-term outcomes in non-ST-segment elevation acute coronary syndromes with respect to age: a single-center registry of 488 consecutive patients. Clin. Cardiol. 27(8), 475–479 (2004).
  • Stone PH, Thompson B, Anderson HV et al. Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: the TIMI III registry. JAMA 275(14), 1104–1112 (1996).
  • Bach RG, Cannon CP, Weintraub WS et al. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann. Intern. Med. 141(3), 186–195 (2004).
  • Liistro F, Angioli P, Falsini G et al. Early invasive strategy in elderly patients with non-ST-segment-elevation acute coronary syndrome: comparison with younger patients regarding 30 day and long term outcome. Heart 91(10), 1284–1288 (2005).
  • Lourenço C, Teixeira R, Antonio N et al. Invasive strategy in non-ST-segment-elevation acute coronary syndromes: risks and benefits in an elderly population. Rev. Port. Cardiol. 29(10), 1451–1472 (2010).
  • Zeymer U. The very elderly selected for invasive strategy: a ‘younger’ subgroup with non-ST-segment-elevation acute coronary syndromes? Rev. Esp. Cardiol. 64(10), 847–848 (2011).
  • Malmberg K, Yusuf S, Gerstein HC et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 102(9), 1014–1019 (2000).
  • [No authors listed]. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Fragmin and Fast Revascularisation During Instability in Coronary Artery Disease Investigators. Lancet 354(9180), 708–715 (1999).
  • O’Donoghue ML, Vaidya A, Afsal R et al. An invasive or conservative strategy in patients with diabetes mellitus and non-ST-segment elevation acute coronary syndromes: a collaborative meta-analysis of randomized trials. J. Am. Coll. Cardiol. 60(2), 106–111 (2012).
  • Wright RS, Anderson JL, Adams CD et al. 2011 ACCF/AHA focused update of the Guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J. Am. Coll. Cardiol. 57(19), 1920–1959 (2011).
  • Dudek D, Chyrchel B, Siudak Z et al. Renal insufficiency increases mortality in acute coronary syndromes regardless of TIMI risk score. Kardiol. Pol. 66(1), 28–34; discussion 35 (2008).
  • Szummer K, Lundman P, Jacobson SH et al.; SWEDEHEART. Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). Circulation 120(10), 851–858 (2009).
  • Januzzi JL, Cannon CP, DiBattiste PM, Murphy S, Weintraub W, Braunwald E; TACTICS-TIMI 18 Investigators. Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial). Am. J. Cardiol. 90(11), 1246–1249 (2002).
  • Woudstra P, Damman P, Clayton T et al. Routine invasive versus selective invasive strategy and long-term outcomes in patients with reduced renal function presenting with non-ST-segment-elevation acute coronary syndrome. J. Am. College of Cardiol. 59(13), E392–E392 (2012).
  • Charytan DM, Wallentin L, Lagerqvist B et al. Early angiography in patients with chronic kidney disease: a collaborative systematic review. Clin. J. Am. Soc. Nephrol. 4(6), 1032–1043 (2009).
  • Jneid H, Anderson JL, Wright RS et al. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 60(7), 645–681 (2012).
  • Bjessmo S, Ivert T, Flink H, Hammar N. Early and late mortality after surgery for unstable angina in relation to Braunwald class. Am. Heart J. 141(1), 9–14 (2001).
  • Tricoci P, Newby LK, Hasselblad V et al. Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trials. Circ. Cardiovasc. Qual. Outcomes 4(4), 448–458 (2011).
  • Neumann FJ, Kastrati A, Pogatsa-Murray G et al. Evaluation of prolonged antithrombotic pretreatment (‘cooling-off’ strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. JAMA 290(12), 1593–1599 (2003).
  • Mehta SR, Granger CB, Boden WE et al.; TIMACS Investigators. Early versus delayed invasive intervention in acute coronary syndromes. N. Engl. J. Med. 360(21), 2165–2175 (2009).
  • Montalescot G, Cayla G, Collet JP et al.; ABOARD Investigators. Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial. JAMA 302(9), 947–954 (2009).
  • Van ‘T Hof AW, De Vries ST, Dambrink JH et al. A comparison of two invasive strategies in patients with non-ST-segment-elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study. 2b/3a upstream therapy and acute coronary syndromes. Eur. Heart J. 24(15), 1401–1405 (2003).
  • Katritsis DG, Siontis GC, Kastrati A et al. Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes. Eur. Heart J. 32(1), 32–40 (2011).
  • Riezebos RK, Ronner E, Ter Bals E et al.; OPTIMA trial. Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromes. Heart 95(10), 807–812 (2009).
  • Ruiz Bailén M, Rucabado Aguilar L, Aguayo de Hoyos E, Brea-Salvago JF. The CRUSADE study, evaluation model of quality in percutaneous coronary intervention. Med. Intensiva 30(6), 276–279 (2006).
  • Gray HH, Henderson RA, de Belder MA, Underwood SR, Camm AJ; Guideline Development Group. Early management of unstable angina and non-ST-segment elevation myocardial infarction: summary of NICE guidance. Heart 96(20), 1662–1668 (2010).
  • Meier P, Windecker S, Lansky AJ. Radial versus femoral access for primary percutaneous coronary intervention: is there a preferred route to the heart? Heart 98(4), 269–270 (2012).
  • Mamas MA, Ratib K, Routledge H et al. Influence of access site selection on PCI-related adverse events in patients with STEMI: meta-analysis of randomised controlled trials. Heart 98(4), 303–311 (2012).
  • Jolly SS, Yusuf S, Cairns J et al.; RIVAL trial group. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet 377(9775), 1409–1420 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.